COVER - shares

Entity Information [Line Items]

Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, Postal Zip Code
Entity Address, City or Town
Entity Address, State or Province
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Document Fiscal Year Focus
Document Fiscal Period Focus (i.e. Q1,Q2,Q3,FY)
Amendment Flag
CIK
Fiscal Year End Date
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding
 6 Months Ended
Dec. 31, 2023 Jan. 30, 2024

10-Q
true
Dec. 31, 2023
false
001-39058
Peloton Interactive, Inc.
DE
47-3533761
441 Ninth Avenue, Sixth Floor
10001
New York
NY
929
567-0006
Class A common stock, $0.000025 par value per share
PTON
NASDAQ
Yes
Yes
Large Accelerated Filer
false
false
false
2024
Q2
false
0001639825
--06-30

348,856,682

18,016,072
 CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Goodwill
Restricted cash
Operating lease right-of-use assets, net
Other assets
Total assets
Current liabilities:
Accounts payable and accrued expenses
Deferred revenue and customer deposits
Current portion of long-term debt and other bank borrowings
Operating lease liabilities, current
Other current liabilities
Total current liabilities
0% Convertible Senior Notes, net
Term loan, net
Operating lease liabilities, non-current
Other non-current liabilities
Total liabilities
Commitments and contingencies (Note 8)
Stockholders’ deficit
Common stock, $0.000025 par value; 2,500,000,000 and 2,500,000,000 Class A shares
authorized, 346,192,530
Additional paid-in capitaland 338,750,774 shares issued and outstanding as of December 31,
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ deficit
Total liabilities and stockholders' deficit
Dec. 31, 2023 Jun. 30, 2023

$ 737.7 $ 813.9
141 97.2
427.2 522.6
220.7 205.4
1,526.5 1,639.1
398.6 444.8
20.1 25.6
41.2 41.2
60.4 71.6
499.3 524.1
23.2 22.7
2,569.4 2,769.1

513.1 478.4
189.2 187.3
7.5 7.5
79.1 83.5
4.4 4.6
793.3 761.4
990.3 988
691.6 690.9
566.3 593.8
27.1 30.1
3,068.6 3,064.2

0 0
4,767.1 4,619.8
19.5 16.8
(5,285.9) (4,931.8)
(499.3) (295.1)
$ 2,569.4 $ 2,769.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares Dec. 31, 2023
Class A Common Stock
Common stock, par value (in dollars per share) $ 0.000025
Common stock, shares authorized (in shares) 2,500,000,000
Common stock, shares issued (in shares) 346,192,530
Common stock, shares outstanding (in shares) 346,192,530
Class B Common Stock
Common stock, par value (in dollars per share) $ 0.000025
Common stock, shares authorized (in shares) 2,500,000,000
Common stock, shares issued (in shares) 18,016,072
Common stock, shares outstanding (in shares) 18,016,072
0% Convertible Senior Notes Due February 15, 2026 | Convertible Debt
Convertible debt, stated interest rate 0%
Jun. 30, 2023

$ 0.000025
2,500,000,000
338,750,774
338,750,774

$ 0.000025
2,500,000,000
18,016,853
18,016,853

0%
 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS - USD ($) $ in Millions
Total revenue
Total cost of revenue
Gross profit
Operating expenses:
Sales and marketing
General and administrative
Research and development
Impairment expense
Restructuring expense
Supplier settlements
Total operating expenses
Loss from operations
Other expense, net:
Interest expense
Interest income
Foreign exchange gain (loss)
Other income, net
Total other expense, net
Loss before provision for income taxes
Income tax (benefit) expense
Net loss
Net loss attributable to Class A and Class B common stockholders
Net loss attributable to Class A and Class B common stockholders
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Weighted-average Class A and Class B common shares outstanding, basic (in shares)
Weighted-average Class A and Class B common shares outstanding, diluted (in shares)
Other comprehensive income:
Change in foreign currency translation adjustment
Derivative adjustments:
Reclassification for derivative adjustments included in Net loss
Total other comprehensive income
Comprehensive loss
Connected Fitness Products
Total revenue
Total cost of revenue
Subscription
Total revenue
Total cost of revenue
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022
$ 743.6 $ 792.7 $ 1,339.2 $ 1,409.2
444.2 557.6 754.4 957
299.4 235 584.8 452.2

230.3 217.1 376.4 355.8

160.8 192.6 311.8 386.1
79.9 80 158.6 168.1
3.6 9.7 27.7 72.6
13.4 49 31.2 155.9
(1.5) 17.9 (1.5) 19.1
486.5 566.4 904.2 1,157.6
(187.1) (331.3) (319.4) (705.3)

(27.7) (22.2) (54.9) (43.2)

8.4 5.8 16.9 9.8
9.6 11.8 1.9 (5.2)
0.1 2.4 0.4 2.6
(9.5) (2.2) (35.7) (35.9)
(196.6) (333.5) (355.1) (741.2)
(1.7) 1.9 (1) 2.7
(194.9) (335.4) (354.1) (743.9)
(194.9) (335.4) (354.1) (743.9)
$ (194.9) $ (335.4) $ (354.1) $ (743.9)
$ (0.54) $ (0.98) $ (0.98) $ (2.18)
$ (0.54) $ (0.98) $ (0.98) $ (2.18)
362,334,326 341,930,937 360,440,945 340,516,100
362,334,326 341,930,937 360,440,945 340,516,100

$ 0.8 $ 3.9 $ 2.7 $ 8.2

0 0.1 0 0.6
0.8 4 2.7 8.9
(194.1) (331.4) (351.5) (735.1)

319.1 381.4 499.7 585.6

305.3 424.2 480.2 684.1

424.5 411.3 839.5 823.6

$ 139 $ 133.4 $ 274.2 $ 272.9
 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions
Cash Flows from Operating Activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
Stock-based compensation expense
Non-cash operating lease expense
Amortization of debt discount and issuance costs
Impairment expense
Loss on sale of subsidiary
Net foreign currency adjustments
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable and accrued expenses
Deferred revenue and customer deposits
Operating lease liabilities, net
Other liabilities
Net cash used in operating activities
Cash Flows from Investing Activities:
Capital expenditures and capitalized internal-use software development costs
Proceeds from sale of subsidiary
Net cash provided by (used in) investing activities
Cash Flows from Financing Activities:
Principal repayment of Term Loan
Proceeds, net from employee stock purchase plan withholdings
Proceeds from employee stock plans
Principal repayments of finance leases
Net cash provided by financing activities
Effect of exchange rate changes
Net change in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash — Beginning of period
Cash, cash equivalents, and restricted cash — End of period
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest
Cash paid for income taxes
Supplemental Disclosures of Non-Cash Investing and Financing Information:
Accrued and unpaid capital expenditures, including software
Stock-based compensation capitalized for software development costs
 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022

$ (354.1) $ (743.9)

55.9 60.9
140.8 263.7
33.7 44.4
7 6.7
27.7 72.6
3.8 0
(1.9) 5.6

(44) (41.4)
80.1 287.5
(21.1) 13
(1.2) 5.3
8.6 (218.5)
1.9 9.6
(44.5) (43.6)
(3) (13.1)
(110.4) (291.3)

(10) (49.5)
14.6 0
4.6 (49.5)

(3.8) (3.8)
1.9 2.8
19.1 29.9
(0.5) (1)
16.8 27.9
1.7 7.1
(87.3) (305.7)
885.5 1,257.6
798.1 951.9

47.8 33.1
1.9 7.6

2.2 2.5
$0 $ 4.4
 CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) -
USD ($) shares in Millions, $ in Millions
Beginning balance (in shares) at Jun. 30, 2022
Beginning balance at Jun. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity related to stock-based compensation (in shares)
Activity related to stock-based compensation
Issuance of common stock under employee stock purchase plan (in shares)
Issuance of common stock under employee stock purchase plan
Other comprehensive income (loss)
Net loss
Ending balance (in shares) at Dec. 31, 2022
Ending balance at Dec. 31, 2022
Beginning balance (in shares) at Sep. 30, 2022
Beginning balance at Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity related to stock-based compensation (in shares)
Activity related to stock-based compensation
Other comprehensive income (loss)
Net loss
Ending balance (in shares) at Dec. 31, 2022
Ending balance at Dec. 31, 2022
Beginning balance (in shares) at Jun. 30, 2023
Beginning balance at Jun. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity related to stock-based compensation (in shares)
Activity related to stock-based compensation
Issuance of common stock under employee stock purchase plan (in shares)
Issuance of common stock under employee stock purchase plan
Other comprehensive income (loss)
Net loss
Ending balance (in shares) at Dec. 31, 2023
Ending balance at Dec. 31, 2023
Beginning balance (in shares) at Sep. 30, 2023
Beginning balance at Sep. 30, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity related to stock-based compensation (in shares)
Activity related to stock-based compensation
Other comprehensive income (loss)
Net loss
Ending balance (in shares) at Dec. 31, 2023
Ending balance at Dec. 31, 2023
Total Cumulative Effect, Period of Adoption, Adjustment

$ 592.9 $ (119.5)

288.8

3.3
8.9
(743.9)

30.5

258.5

103.4
4
(335.4)

30.5

(295.1)

145.3

2
2.7
(354.1)

(499.3)

(370.9)

65.7
0.8
(194.9)

$ (499.3)
Common Stock Class A and Class B Common Stock Additional Paid-In Capital
338.3
$0 $ 4,291.3

5.9
288.8
0.4
3.3

344.6
$0 4,423.4
339.8
$0 4,320

4.6
103.4

344.6
$0 4,423.4
356.8
$0 4,619.8

7
145.3
0.4
2

364.2
$0 4,767.1
360.4
$0 4,701.4

3.8
65.7

364.2
$0 $ 4,767.1
Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment

$ (160.1)
Accumulated Other Comprehensive Income Accumulated Deficit

$ 12.2 $ (3,710.6)

8.9
(743.9)

21.1 (4,414)

17.1 (4,078.6)

4
(335.4)

21.1 (4,414)

16.8 (4,931.8)

2.7
(354.1)

19.5 (5,285.9)

18.7 (5,091)

0.8
(194.9)

$ 19.5 $ (5,285.9)
Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment

$ 40.6
 Description of Business and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation
 6 Months Ended
Dec. 31, 2023

Description of Business and Basis of Presentation Description and Organization Peloton is the
largest interactive fitness platform in the world with a loyal community of Members, which
 Summary of Significant Accounting Policies
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
 6 Months Ended
Dec. 31, 2023

Summary of Significant Accounting Policies Use of Estimates The preparation of these

financial statements requires the Company to make estimates and judgments that affect the
 Revenue
Revenue from Contract with Customer [Abstract]
Revenue
 6 Months Ended
Dec. 31, 2023

Revenue The Company’s primary sources of revenue are its recurring content Subscription
revenue, revenue from sales of its Connected Fitness Products, rental lease arrangements,
 Restructuring
Restructuring and Related Activities [Abstract]
Restructuring
 6 Months Ended
Dec. 31, 2023

Restructuring In February 2022, the Company announced and began implementing a

restructuring plan to realign the Company’s operational focus to support its multi-year
 Fair Value Measurements
Fair Value Disclosures [Abstract]
Fair Value Measurements
 6 Months Ended
Dec. 31, 2023

Fair Value Measurements Fair Value Measurements of Other Financial Instruments The
following tables present the estimated fair values of the Company’s financial instruments that
 Inventories
Inventory Disclosure [Abstract]
Inventories
 6 Months Ended
Dec. 31, 2023

Inventories Inventories were as follows: December 31, 2023 June 30, 2023 (in millions) Raw
materials $ 43.9 $ 53.2 Finished products (1) 590.3 703.0 Total inventories 634.1 756.2 Less:
 Debt
Debt Disclosure [Abstract]
Debt
 6 Months Ended
Dec. 31, 2023

Debt Convertible Notes and the Indenture In February 2021, the Company issued $1.0 billion
aggregate principal amount of the Notes in a private offering, including the exercise in full of
 Commitments and Contingencies
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
 6 Months Ended
Dec. 31, 2023

Commitments and Contingencies The Company is subject to minimum guarantee royalty

payments associated under certain music license agreements. The following represents the
 Equity-Based Compensation
Share-Based Payment Arrangement [Abstract]
Equity-Based Compensation
 6 Months Ended
Dec. 31, 2023

Equity-Based Compensation 2019 Equity Incentive Plan In August 2019, the Board of
Directors adopted the 2019 Equity Incentive Plan (the “2019 Plan”), which was subsequently
 Income Taxes
Income Tax Disclosure [Abstract]
Income Taxes
 6 Months Ended
Dec. 31, 2023

Income Taxes The Company recorded a benefit from income taxes of $(1.7) million and $(1.0)
million for the three and six months ended December 31, 2023, respectively, and a provision
 Net Loss Per Share
Earnings Per Share [Abstract]
Net Loss Per Share
 6 Months Ended
Dec. 31, 2023

Net Loss Per Share The computation of loss per share is as follows: Three Months Ended
December 31, Six Months Ended December 31, 2023 2022 2023 2022 ($ in millions except per
 Segment Information
Segment Reporting [Abstract]
Segment Information
 6 Months Ended
Dec. 31, 2023

Segment Information The Company applies ASC 280, Segment Reporting , in determining
reportable segments. The Company has two reportable segments: Connected Fitness Products
 3 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Millions
Dec. 31, 2023 Dec. 31, 2022
Pay vs Performance Disclosure
Net loss $ (194.9) $ (335.4)
 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022

$ (354.1) $ (743.9)
 Insider Trading Arrangements
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Andy Rendich [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Adoption Date
Arrangement Duration
Jennifer Cotter [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Adoption Date
Arrangement Duration
Andy Rendich Trading Arrangement, Common Stock [Member] | Andy Rendich [Member]
Trading Arrangements, by Individual
Aggregate Available
Andy Rendich Trading Arrangement, Restricted Stock Units [Member] | Andy Rendich
[Member]
Trading Arrangements, by Individual
Aggregate Available
Jennifer Cotter Trading Arrangement, Common Stock [Member] | Jennifer Cotter [Member]
Trading Arrangements, by Individual
Aggregate Available
Jennifer Cotter Trading Arrangement, Stock Options [Member] | Jennifer Cotter [Member]
Trading Arrangements, by Individual
Aggregate Available
Jennifer Cotter Trading Arrangement, Restricted Stock Units [Member] | Jennifer Cotter
[Member]
Trading Arrangements, by Individual
Aggregate Available
 3 Months Ended
Dec. 31, 2023 shares

false
false
false

Andy Rendich
Chief Supply Chain Officer
true
November 27, 2023
365 days

Jennifer Cotter
Chief Content Officer
true
December 7, 2023
363 days

94,188

254,364

43,410

336,750

498,239
 6 Months Ended
Dec. 31, 2023 shares

On November 27, 2023, Andy Rendich, our Chief Supply Chain Officer, entered into a pre-
arranged stock trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c)

On December 7, 2023, Jennifer Cotter, our Chief Content Officer, entered into a Rule 10b5-1
Plan. Ms. Cotter’s Rule 10b5-1 Plan provides for the potential aggregate sale of (i) 43,410

94,188

254,364

43,410

336,750

498,239
 Summary of Significant Accounting Policies (Policies)
Accounting Policies [Abstract]
Basis of Presentation and Consolidation
Use of Estimates
Internal-Use Software
Recently Adopted Accounting Pronouncements and Accounting Pronouncements Not Yet
Adopted
Revenue
Deferred Revenue and Customer Deposits
Fair Value Measurements
 6 Months Ended
Dec. 31, 2023

The accompanying interim condensed consolidated financial statements have been prepared
in
Useaccordance with
of Estimates Theaccounting
preparation principles
of thesegenerally
financial accepted
statements in requires
the UnitedtheStates ("GAAP")
Company to make
estimates and judgments that affect the reported amounts of assets,
Internal-Use Software The Company incurs development costs related to internal-useliabilities, revenue,
software. These software
Recently Adopted Accountingdevelopment costs meet
Pronouncements ASU the criteriaIn
2021-08 forOctober
capitalization
2021, theonce the
Financial
Accounting
The Company’sStandards
primary Board issued
sources Accounting
of revenue Standards
are its recurring Update
content(“ASU”) 2021-08,
Subscription Business
revenue,
revenue
Deferredfrom salesand
Revenue of its Connected
Customer FitnessDeferred
Deposits Products, rental lease
revenue arrangements,
is recorded accessories,
for nonrefundable
cash payments
The fair value ofreceived for the Company’s
the 0% Convertible Senior performance obligation
Notes due February 15, to transfer,
2026 or standisready
(the “Notes”)
determined based on the closing price on the last trading day of the reporting period.
 Revenue (Tables)
Revenue from Contract with Customer [Abstract]
Schedule of Product Warranty Liability
Schedule of Disaggregation of Revenue
 6 Months Ended
Dec. 31, 2023

Activity related to the Company’s accrual for our estimated future product warranty
obligation was as
The Company’s follows:disaggregated
revenue Three MonthsbyEnded December
geographic 31,was
region Six as
Months Ended
follows: December
Three Months
Ended December 31, Six Months Ended December 31, 2023 2022 2023 2022 (in millions)
 Restructuring (Tables)
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges
Schedule of Restructuring Related Liabilities
 6 Months Ended
Dec. 31, 2023

As a result of the Restructuring Plan, the Company incurred the charges shown in the
following table,tables
The following of which Asset
present write-downsof
a roll-forward and write-offs
cash are included within
restructuring-related Impairment
liabilities, which is
included within Accounts payable and accrued expenses in the Condensed Consolidated
 Fair Value Measurements (Tables)
Fair Value Disclosures [Abstract]
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments
 6 Months Ended
Dec. 31, 2023

The following tables present the estimated fair values of the Company’s financial instruments
that are not recorded at fair value on the Condensed Consolidated Balance Sheets: As of
 Inventories (Tables)
Inventory Disclosure [Abstract]
Schedule of Inventories
 6 Months Ended
Dec. 31, 2023

Inventories were as follows: December 31, 2023 June 30, 2023 (in millions) Raw materials $
43.9 $ 53.2 Finished products (1) 590.3 703.0 Total inventories 634.1 756.2 Less: Reserves
 Debt (Tables)
Debt Disclosure [Abstract]
Schedule of Convertible Debt
 6 Months Ended
Dec. 31, 2023

The net carrying amount of the liability component of the Notes was as follows: December 31,
2023 June 30, 2023 (in millions) Principal $ 1,000.0 $ 1,000.0 Unamortized debt issuance
 Commitment and Contingencies (Tables)
Commitments and Contingencies Disclosure [Abstract]
Schedule of Minimum Guarantee Royalty Payments Due Under Music License Agreements
Schedule of Actual and Future Returns and Written Down and Logistics Costs
 6 Months Ended
Dec. 31, 2023

The following represents the Company's minimum annual guarantee payments under music
license agreements
The following table for the next
details three years as of December
the (benefit)/reduction 31, 2023
to Connected : Future
Fitness Minimum
Products revenue for
actual and future returns and costs associated with the Tread+ product recall that were
 Equity-Based Compensation (Tables)
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity
Schedule of Fair Value Assumptions
Schedule of Restricted Stock and Restricted Stock Units
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation
Assumptions
Schedule of Stock-based Compensation Expense
 6 Months Ended
Dec. 31, 2023

The following summary sets forth the stock option activity under the 2019 Plan: Options
Outstanding
The fair valueNumber
of each of Stockwas
option Options Weighted-Average
estimated Exercise
at the grant date using Price Weighted-Average
the Black-Scholes method
with the following assumptions: Six Months Ended December 31, 2022 Weighted average
The following table summarizes the activity related to the Company's restricted stock and
restricted stock units:
The Black-Scholes Restricted
option pricing Stock
modelUnits Outstanding
assumptions usedNumber of Awards
to calculate the fairWeighted-
value of shares
estimated to be purchased at the commencement of the ESPP offering periods
The Company's total stock-based compensation expense was as follows: Three Months were as Ended
December 31, Six Months Ended December 31, 2023 2022 2023 2022 (in millions) Cost of
 Net Loss Per Share (Tables)
Earnings Per Share [Abstract]
Schedule of Computation of Basic and Diluted Net (Loss) Income Per Share
Schedule of Potentially Diluted Securities Not Included in Calculation of Diluted Shares
Outstanding
 6 Months Ended
Dec. 31, 2023

The computation of loss per share is as follows: Three Months Ended December 31, Six
Months Endedpotentially
The following December dilutive
31, 2023shares
2022 2023 2022
were not ($ in millions
included except per share
in the calculation amounts)
of diluted shares
outstanding as the effect would have been anti-dilutive: Three Months Ended December 31,
 Segment Information (Tables)
Segment Reporting [Abstract]
Schedule of Key Performance Measures by Segment
Schedule of Reconciliation of Segment Gross Profit to Consolidated Loss Before Tax
 6 Months Ended
Dec. 31, 2023

Key financial performance measures of the segments including Revenue, Cost of revenue, and
Gross profit are as between
The reconciliation follows: Three Months
reportable Ended Gross
Segment December
Profit31,
to Six Months Ended
consolidated December
Loss before
provision for income tax is as follows: Three Months Ended December 31, Six Months Ended
 Summary of Significant Accounting Policies (Details) Dec. 31, 2023
Maximum | Internal-Use Software
Property and Equipment [Line Items]
Useful life 3 years
 3 Months Ended
Revenue - Narrative (Details) - USD ($) $ in Millions
Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Allowable product return period (in days)
Standard product warranty period (in years)
Total revenue $ 743.6
Deferred revenue 94.9
Customer deposits 94.3
Revenue recognized that was previously included in deferred revenue
United States
Disaggregation of Revenue [Line Items]
Total revenue $ 658
United States | Revenue Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of total revenue 88%
Minimum
Disaggregation of Revenue [Line Items]
Extended product warranty period (in months)
Maximum
Disaggregation of Revenue [Line Items]
Extended product warranty period (in months)
3 Months Ended 6 Months Ended
Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022 Jun. 30, 2023

30 days
1 year
$ 792.7 $ 1,339.2 $ 1,409.2
94.9 $ 99.2
94.3 $ 88.1
92.5 90.7

$ 711.7 $ 1,186.1 $ 1,256.8

90% 89% 89%

12 months

36 months
 Revenue - Standard Product Warranty (Details) - USD ($) $ in Millions
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease)
[Roll Forward]
Balance at beginning of period
Provision for warranty accrual
Warranty claims
Balance at end of period
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 20.7 $ 36.7 $ 26.4 $ 51.1

7.9 8.6 9.7 5.8
(7.2) (9.2) (14.7) (20.7)
$ 21.5 $ 36.2 $ 21.5 $ 36.2
 3 Months Ended
Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Millions
Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue $ 743.6
North America
Disaggregation of Revenue [Line Items]
Total revenue 686.3
International
Disaggregation of Revenue [Line Items]
Total revenue $ 57.4
3 Months Ended 6 Months Ended
Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 792.7 $ 1,339.2 $ 1,409.2

737.5 1,235 1,304.1

$ 55.2 $ 104.1 $ 105.1

 1 Months Ended
Restructuring - Narrative (Details) - USD ($) $ in Millions
Jan. 31, 2024
Restructuring Cost and Reserve [Line Items]
Proceeds from sale of subsidiary
Non cash charges
Subsequent Event
Restructuring Cost and Reserve [Line Items]
Proceeds from sale of subsidiary $ 31.9
Employee Reduction, Facility Closings | Forecast
Restructuring Cost and Reserve [Line Items]
Expected cost
Asset Impairment and Stock Based Compensation Charges | Forecast
Restructuring Cost and Reserve [Line Items]
Non cash charges
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022 Jun. 30, 2024

$ 14.6 $0
$ 5.6 $ 19.3 $ 36.1 $ 159

$ 20

$ 10
 Restructuring - Schedule of Restructuring Charges (Details) - USD ($) $ in Millions
Cash restructuring charges:
Severance and other personnel costs
Exit and disposal costs and professional fees
Total cash charges
Non-cash charges:
Asset write-downs and write-offs
Stock-based compensation expense
Write-offs of inventory related to restructuring activities
Loss on sale of subsidiary
Total non-cash charges
Total
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 0.3 $ 34.1 $ 6.4 $ 61.1

9.3 8.9 13.8 12
9.6 43 20.2 73.1

1.3 9.7 24.1 72.6

0 6 7.2 82.8
0.5 3.7 1 3.7
3.8 0 3.8 0
5.6 19.3 36.1 159
$ 15.2 $ 62.4 $ 56.4 $ 232.2
 Restructuring - Schedule of Restructuring Related Liabilities (Details) - USD ($) $ in
Millions
Restructuring Reserve [Roll Forward]
Beginning Balance
Charges
Cash payments
Ending Balance
Severance and other personnel costs
Restructuring Reserve [Roll Forward]
Beginning Balance
Charges
Cash payments
Ending Balance
Exit and disposal costs and professional fees
Restructuring Reserve [Roll Forward]
Beginning Balance
Charges
Cash payments
Ending Balance
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 6.5 $ 17.1 $ 13.9 $ 10.9

9.6 43 20.2 73.1
(9.1) (36.7) (27.2) (60.6)
7 23.4 7 23.4

5.9 15.5 13.6 10.9

0.3 34.1 6.4 61.1
(3.9) (27.4) (17.8) (49.8)
2.2 22.3 2.2 22.3

0.6 1.5 0.3 0

9.3 8.9 13.8 12
(5.2) (9.3) (9.4) (10.9)
$ 4.7 $ 1.1 $ 4.7 $ 1.1
 Fair Value Measurements - Other Financial Instruments (Details) - USD ($) $ in Millions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line
Items]
Convertible senior notes
0% Convertible Senior Notes Due February 15, 2026 | Convertible Debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line
Items]
Convertible debt, stated interest rate
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line
Items]
Convertible senior notes
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line
Items]
Convertible senior notes
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line
Items]
Convertible senior notes
Dec. 31, 2023 Jun. 30, 2023

$ 778.8 $ 759.5

0% 0%

$0 $0

778.8 759.5

$0 $0
 Fair Value Measurements - Narrative (Details) Dec. 31, 2023
0% Convertible Senior Notes Due February 15, 2026 | Convertible Debt
Debt Instrument [Line Items]
Convertible debt, stated interest rate 0%
Jun. 30, 2023

0%
 Inventories (Details) - USD ($) $ in Millions Dec. 31, 2023 Jun. 30, 2023
Inventory Disclosure [Abstract]
Raw materials $ 43.9 $ 53.2
Finished products 590.3 703
Total inventories 634.1 756.2
Less: Reserves (207) (233.6)
Total inventories, net 427.2 522.6
Other inventory, in transit $ 46 $ 26.4
 Inventories - Narrative (Details) - USD ($) $ in Millions Dec. 31, 2023 Jun. 30, 2023
Inventory [Line Items]
Inventory reserves $ 207 $ 233.6
Inventory related to returned products 82.4
Excess Accessories and Apparel
Inventory [Line Items]
Inventory reserves $ 97.3
Debt - Convertible Notes and Indenture (Details) - Convertible Debt - Convertible Notes
Maturing February 15, 2026
Line of Credit Facility [Line Items]
Principal amount
Value of shares available for exercise
Proceeds from convertible debt
Debt instrument, conversion ratio
Debt instrument, conversion price (in dollars per share) | $ / shares
Redemption price percentage
Debt Conversion Terms One
Line of Credit Facility [Line Items]
Threshold percentage of stock price trigger
Threshold of trading days | period
Threshold of consecutive trading days | period
 1 Months Ended
Feb. 28, 2021 USD ($) period $ / shares

$ 1,000,000,000
125,000,000
$ 977,200,000
0.00418
$ 239.23
100%

130%
20
30
 Debt - Components of Convertible Debt (Details) - Convertible Debt - USD ($) $ in
Millions
0% Convertible Senior Notes Due February 15, 2026
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
[Abstract]
Principal
Unamortized debt issuance costs
Net carrying amount
Convertible Senior Notes Outstanding On November 16, 2025 | Term Loan Facility
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
[Abstract]
Principal
Principal payments
Unamortized debt discount
Unamortized debt issuance costs
Net carrying amount
Dec. 31, 2023 Jun. 30, 2023

$ 1,000 $ 1,000
(9.7) (12)
990.3 988

750 750
(11.3) (7.5)
(25) (27.8)
(14.7) (16.3)
$ 699.1 $ 698.4
 3 Months Ended
Debt - Components of Interest Expense (Details) - USD ($) $ in Millions
Dec. 31, 2023
Interest Expense, Debt [Abstract]
Amortization of debt issuance costs $ 1.1
Total interest expense related to the Notes 1.1
Term Loan Facility
Interest Expense, Debt [Abstract]
Amortization of debt discount 1.5
Amortization of debt issuance costs 0.9
Total interest expense related to the Notes $ 2.3
3 Months Ended 6 Months Ended
Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 1.1 $ 2.3 $ 2.3

1.1 2.3 2.3

1.4 2.8 2.7

0.8 1.7 1.6
$ 2.2 $ 4.5 $ 4.4
 Debt - Capped Call Transactions (Details) - 0% Convertible Senior Notes Due February
15, 2026 - Call Option - Convertible Debt $ / shares in Units, shares in Millions, $ in
Millions
Line of Credit Facility [Line Items]
Capped calls, option strike price (in dollars per share)
Capped calls, cap price (in dollars per share)
Shares covered under call feature (in shares) | shares
Capped call purchase price | $
 1 Months Ended
Feb. 28, 2021 USD ($) $ / shares shares

$ 239.23
$ 362.48
6.9
$ 81.3
 Debt - Second Amended and Restated Credit Agreement (Details) - USD ($)
Term Loan Facility | Line of Credit
Line of Credit Facility [Line Items]
Proceeds from lines of credit
Debt discount
Debt issuance costs
Effective interest rate
Letter of Credit
Line of Credit Facility [Line Items]
Standby letters of credit outstanding
Second Amended and Restated Credit Agreement | Term Loan Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity
Maximum borrowing capacity (greater than)
Quarterly installments payable
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Term Loan Facility | Line of Credit | SOFR
Line of Credit Facility [Line Items]
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Term Loan Facility | Line of Credit | SOFR |
Floor Rate
Line of Credit Facility [Line Items]
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Term Loan Facility | Line of Credit |
Alternative Base
Line of Credit Rate [Line Items]
Facility
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Term Loan Facility | Line of Credit |
Alternative Base
Line of Credit Rate | Floor
Facility [Line Rate
Items]
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Term Loan Facility | Convertible Senior
Notes
Line ofOutstanding On November
Credit Facility 16, 2025
[Line Items]
Maximum borrowing capacity (greater than)
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity
Line of credit facility, liquidity covenant
Line of credit facility, maximum amount outstanding during period
Line of credit facility, non-consenting commitments reduced
Line of credit facility, consenting commitments reduced
Debt issuance costs of revolving credit facility
Commitment fees incurred
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
SOFR | Floor
Line of Rate
Credit Facility [Line Items]
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
Alternative Base
Line of Credit Rate [Line Items]
Facility
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
June
Line 20, 2024 Maturity
of Credit Facility [Line Items]
Commitment fee percentage
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
June
Line 20, 2024 Maturity
of Credit | SOFRItems]
Facility [Line
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
December 10, 2026
Line of Credit Maturity
Facility [Line Items]
Commitment fee percentage
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
December 10, 2026
Line of Credit Maturity
Facility [Line |Items]
SOFR
Basis spread on variable rate
Second Amended and Restated Credit Agreement | Revolving Credit Facility | Line of Credit |
December 10, 2026
Line of Credit Maturity
Facility [Line |Items]
Alternative Base Rate
Basis spread on variable rate
Second Amended Credit Agreement | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity
Second Amended Credit Agreement | Revolving Credit Facility | Line of Credit | June 20, 2024
Maturity
Line of Credit Facility [Line Items]
Maximum borrowing capacity
Second Amended Credit Agreement | Revolving Credit Facility | Line of Credit | December 10,
2026 Maturity
Line of Credit Facility [Line Items]
Maximum borrowing capacity
 3 Months Ended 6 Months Ended
May 02, 2023 Aug. 24, 2022 May 25, 2022 Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023

$ 696,400,000
$ 33,800,000 33,800,000
$ 19,800,000 $ 19,800,000
14.50% 14.50%

$ 60,400,000 $ 60,400,000

$ 750,000,000
738,800,000 738,800,000
0.25%
0.50%

6.50%

0.50%

5.50%

1%

$ 200,000,000

$ 400,000,000
$ 250,000,000
3,000,000,000 $ 3,000,000,000
28,000,000
$ 372,000,000
$ 1,100,000
$ 300,000 $ 400,000 $ 700,000
 0%

1.75%

0.375%

2.75%

0.325%

2.25%

1.25%
6 Months Ended
Dec. 31, 2022 Nov. 25, 2023 May 25, 2023 Nov. 25, 2022 Nov. 24, 2022 Dec. 10, 2021

14.50% 14.30% 13.70% 10.20%

$ 500,000,000

$ 800,000
 500,000,000

35,000,000

$ 465,000,000
Commitments and Contingencies - Minimum Guarantee Royalty Payments Due (Details)
- Royalty Guarantees, Commitments $ in Millions
Future Minimum Payments
2024 (remaining)
2025
2026
Total
Dec. 31, 2023 USD ($)

$ 50.4
48.8
6
$ 105.2
 Commitment and Contingencies - Actual and Future Returns and Written Down and
Logistics Costs (Details) - USD ($) $ in Millions
Other Commitments [Line Items]
Returns accrual for (benefit)/reduction to Connected Fitness Products revenue
Costs of product recalls
Connected Fitness Products
Other Commitments [Line Items]
Returns accrual for (benefit)/reduction to Connected Fitness Products revenue
Costs of product recalls
Connected Fitness Products
Other Commitments [Line Items]
Returns accrual for (benefit)/reduction to Connected Fitness Products revenue
Costs of product recalls
Connected Fitness Products | Connected Fitness Products
Other Commitments [Line Items]
Costs of product recalls
Connected Fitness Products | Sales Returns and Allowances
Other Commitments [Line Items]
Returns accrual for (benefit)/reduction to Connected Fitness Products revenue
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 743.6 $ 792.7 $ 1,339.2 $ 1,409.2

444.2 557.6 754.4 957

319.1 381.4 499.7 585.6

305.3 424.2 480.2 684.1

319.1 381.4 499.7 585.6

305.3 424.2 480.2 684.1

(4.2) 0 (4.3) 2.5

$ (2.3) $0 $ (3.9) $ 26.5

 Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions
Apr. 17, 2023
Other Commitments [Line Items]
Amount awarded to other party
Amount awarded from other party $ 14
Estimate of potential damages and attorney fees
Manufactured Product
Other Commitments [Line Items]
Commitments to contract with third-party manufacturers
Commitments to contract with third-party manufacturers next twelve months
Sales Returns and Allowances | Product Recalls
Other Commitments [Line Items]
Accrued of estimated contingent loss expense
Sales Returns and Allowances | Connected Fitness Products
Other Commitments [Line Items]
Return reserve liability
Accounts payable and accrued expenses
 1 Months Ended
Aug. 04, 2022 Dec. 31, 2022 Dec. 31, 2023 Jun. 30, 2023

$ 19.1

$ 107

$ 139.1
128.4

$ 42.2 2.5

8.5 $ 24.4
$ 10 $ 10
 Equity-Based Compensation - Narrative (Details) $ / shares in Units, $ in Millions
Class of Stock [Line Items]
Aggregate intrinsic value | $
Exercised, weighted-average exercise price (in dollars per share) | $ / shares
Stock-based compensation expense | $
Weighted-average grant date fair value per option (in dollars per share) | $ / shares
Stock-based compensation expense | $
Number of employees eligible, terminated their employment | employee
Minimum
Class of Stock [Line Items]
Post-termination period during which an employee may exercise outstanding stock options
extended
Maximumterm
Class of Stock [Line Items]
Post-termination period during which an employee may exercise outstanding stock options
extended term
2019 Equity Incentive Plan
Class of Stock [Line Items]
Original exercise price lower range (in dollars per share) | $ / shares
Original exercise price upper range (in dollars per share) | $ / shares
Granted (in shares) | shares
Exercised, weighted-average exercise price (in dollars per share) | $ / shares
Severance Plan
Class of Stock [Line Items]
Number of employees eligible, terminated their employment | employee
Severance Plan | Minimum
Class of Stock [Line Items]
Post-termination period during which an employee may exercise outstanding stock options
extended
Severanceterm
Plan | Maximum
Class of Stock [Line Items]
Post-termination period during which an employee may exercise outstanding stock options
extended
ESPP term
Class of Stock [Line Items]
Expected dividend yield
Stock-based compensation expense | $
Unrecognized stock-based compensation expense | $
Unrecognized stock-based compensation expense, period for recognition (in years)
ESPP | 2019 Employee Stock Purchase Plan
Class of Stock [Line Items]
Number of purchase periods | period
Purchase period (in months)
Commencement of offering period (in years)
Commencement of purchase period (in months)
Employee Stock Options
Class of Stock [Line Items]
Expected dividend yield
Unrecognized stock-based compensation expense | $
Unrecognized stock-based compensation expense, period for recognition (in years)
Class A Common Stock | 2019 Equity Incentive Plan
Class of Stock [Line Items]
Increase in number of shares authorized, as a percentage of total common stock outstanding
Increase in number of shares available for future issuance (in shares) | shares
Number of shares available for future issuance (in shares) | shares
Class A Common Stock | ESPP
Class of Stock [Line Items]
Number of shares purchased under ESPP (in shares) | shares
Weighted-average price of shares purchased under ESPP (in dollars per share) | $ / shares
Class A Common Stock | ESPP | 2019 Employee Stock Purchase Plan
Class of Stock [Line Items]
Increase in number of shares authorized, as a percentage of total common stock outstanding
Increase in number of shares available for future issuance (in shares) | shares
Number of shares available for future issuance (in shares) | shares
Purchase price of common stock, percentage of fair market value
 1 Months Ended 3 Months Ended
Jul. 01, 2022 USD ($) $ / shares shares Sep. 30, 2019 period Dec. 31, 2023 USD ($) shares

$ 21.9

$ 66.6

$ 12.94
$ 146.79
2,138
$ 9.13

2
10.2

4
6 months
2 years
6 months
 $ 542.8

5%

80,916,418

1%

15,821,314
85%
3 Months Ended 6 Months Ended
Dec. 31, 2022 USD ($) Dec. 31, 2023 USD ($) employee $ / shares shares

$5
$ 3.56
$ 4.9 $ 5.4
$0
81.6 $ 140.8
9

90 days

2 years 9 months 18 days

90 days

1 year

0%
$ 4.3 $ 3.1
$ 10.2
1 year 8 months 12 days
 $ 542.8
2 years 7 months 6 days

80,916,418

15,821,314
nths Ended 30 Months Ended
Dec. 31, 2022 USD ($) $ / shares Aug. 31, 2023 $ / shares shares Oct. 31, 2023 shares

$ 17.3

$ 48.3
$ 6.42
$ 263.7

$ 11.9
0%

36,000,000

373,114
$ 5.42
Jul. 01, 2023 shares
17,838,381

3,567,676
Equity-Based Compensation - Summary of Stock Options Outstanding (Details) - USD ($)
$ / shares in Units, $ in Millions
Stock Options Outstanding, Number of Stock Options
Stock options outstanding, beginning balance (in shares)
Exercised (in shares)
Forfeited or expired (in shares)
Stock options outstanding, ending balance (in shares)
Stock options vested and exercisable (in shares)
Stock Options Outstanding, Weighted-Average Exercise Price
Stock options outstanding, weighted average exercise price, beginning balance (in dollars per
share)
Exercised, weighted-average exercise price (in dollars per share)
Forfeited or expired, weighted-average exercise price (in dollars per share)
Stock options outstanding, weighted average exercise price, ending balance (in dollars per
share)
Stock options vested and exercisable, weighted-average exercise price (in dollars per share)
Stock options outstanding, weighted-average remaining contractual term (in years)
Stock options vested and exercisable, weighted-average remaining contractual term (in years)
Stock options outstanding, aggregate intrinsic value
Stock options exercised, aggregate intrinsic value
Stock options outstanding, aggregate intrinsic value
Stock options vested and exercisable, aggregate intrinsic value
 6 Months Ended 12 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Jun. 30, 2023

42,999,273
(1,411,592)
(8,859,317)
32,728,364 42,999,273
24,086,928

$ 19.71
3.56
26.32
18.62 $ 19.71
$ 16.14
5 years 6 months 5 years 2 months 12 days
4 years 8 months 12 days
$ 33.2
5 $ 17.3
18.8 $ 33.2
$ 18.8
 Equity-Based Compensation - Summary of Unvested Stock Option Activity (Details)
Options
Unvested options, beginning balance (in shares) | shares
Vested (in shares) | shares
Forfeited or expired (in shares) | shares
Unvested options, ending balance (in shares) | shares
Weighted-Average Grant Date Fair Value
Unvested options, weighted-average grant date fair value, beginning balance (in dollars per
share) | $ options,
Unvested / shares weighted-average grant date fair value, vested (in dollars per share) | $ /
shares
Unvested options, weighted-average grant date fair value, forfeited or expired (in dollars per
share) | $ options,
Unvested / shares weighted-average grant date fair value, ending balance (in dollars per
share) | $ / shares
 6 Months Ended
Dec. 31, 2023 $ / shares shares

12,407,094
(2,571,700)
(1,193,958)
8,641,436

$ 18.84
19.17
18.55
$ 18.78
 Equity-Based Compensation - Summary of Fair Value Assumptions (Details)
Employee stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average risk-free interest rate
Weighted average expected term (in years)
Weighted average expected volatility
Expected dividend yield
Shares estimated to be purchased under ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average risk-free interest rate
Weighted average expected term (in years)
Weighted average expected volatility
Expected dividend yield
 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022

3.30%
6 years 2 months 12 days
81.40%
0%

2%
1 year 3 months 18 days
92.70%
0%
 Equity-Based Compensation - Summary of Restricted Stock and Restricted Stock Units
(Details) - Restricted Stock
Number of Awards
Outstanding, beginning balance (in shares) | shares
Granted (in shares) | shares
Vested and converted to shares (in shares) | shares
Cancelled (in shares) | shares
Outstanding, ending balance (in shares) | shares
Weighted-Average Grant Date Fair Value
Outstanding, weighted-average grant date fair value, beginning balance (in dollars per share) |
$ / sharesweighted-average grant date fair value (in dollars per share) | $ / shares
Granted,
Vested and converted to shares, weighted-average grant date fair value (in dollars per share) |
$ / shares weighted-average grant date fair value (in dollars per share) | $ / shares
Cancelled,
Outstanding, weighted-average grant date fair value, ending balance (in dollars per share) |
$ / shares
 6 Months Ended
Dec. 31, 2023 $ / shares shares

27,236,428
28,369,193
(5,628,613)
(4,706,518)
45,270,490

$ 13.96
6.43
15.14
12.09
$ 9.29
Equity-Based Compensation - Summary of Sock-Based Compensation Expense (Details)
- USD ($) $ in Millions
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Cost of revenue | Connected Fitness Products
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Cost of revenue | Subscription
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
Restructuring expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 66.6 $ 81.6 $ 140.8 $ 263.7

12.6 12 24.6 32.1

2.6 2 4.9 9.3

10 10 19.7 22.7

6 7.5 10.7 18.2

32.2 40.5 67.6 92.8

15.8 15.6 30.7 37.8

$0 $6 $ 7.2 $ 82.8
 3 Months Ended
Income Taxes (Details) - USD ($) $ in Millions
Dec. 31, 2023 Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income tax (benefit) expense $ (1.7) $ 1.9
Effective tax rate 0.88% (0.58%)
 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022

$ (1) $ 2.7
0.27% (0.37%)
 Net Loss Per Share - Schedule of Computation of Basic and Diluted net (Loss) Income
Per Share (Details) - USD ($) $ / shares in Units, $ in Millions
Basic and diluted loss per share:
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Shares used in computation:
Weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)
Basic loss per share (in dollars per share)
Diluted loss per share (in dollars per share)
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ (194.9) $ (335.4) $ (354.1) $ (743.9)

$ (194.9) $ (335.4) $ (354.1) $ (743.9)

362,334,326 341,930,937 360,440,945 340,516,100

362,334,326 341,930,937 360,440,945 340,516,100
$ (0.54) $ (0.98) $ (0.98) $ (2.18)
$ (0.54) $ (0.98) $ (0.98) $ (2.18)
 Net Loss Per Share - Schedule of Potentially Diluted Securities Not Included In
Calculation of Diluted Shares Outstanding (Details) - shares
Employee stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from calculation of diluted shares outstanding (in shares)
Restricted stock units and awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from calculation of diluted shares outstanding (in shares)
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

7,693,440 14,864,037 8,198,291 15,404,476

637,660 817,901 815,567 475,649

 Net Loss Per Share - Narrative (Details)
Convertible Notes Maturing February 15, 2026 | Convertible Debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Debt instrument, conversion price (in dollars per share)
Feb. 28, 2021 $ / shares

$ 239.23
 Segment Information - Schedule of Key Performance Measures by Segment (Details) $
in Millions
Segment Reporting [Abstract]
Number of reportable segments | segment
Segment Reporting Information [Line Items]
Revenue
Cost of revenue
Gross profit
Connected Fitness Products
Segment Reporting Information [Line Items]
Revenue
Cost of revenue
Gross profit
Subscription
Segment Reporting Information [Line Items]
Revenue
Cost of revenue
Gross profit
 3 Months Ended 6 Months Ended
Dec. 31, 2023 USD ($) Dec. 31, 2022 USD ($) Dec. 31, 2023 USD ($) segment

$ 743.6 $ 792.7 $ 1,339.2

444.2 557.6 754.4
299.4 235 584.8

319.1 381.4 499.7

305.3 424.2 480.2
13.8 (42.8) 19.5

424.5 411.3 839.5

139 133.4 274.2
$ 285.6 $ 277.9 $ 565.3
Months Ended
Dec. 31, 2022 USD ($)

$ 1,409.2
957
452.2

585.6
684.1
(98.4)

823.6
272.9
$ 550.7
 Segment Information - Reconciliation of Segment Gross Profit to Consolidated (Details)
- USD ($) $ in Millions
Segment Reporting [Abstract]
Segment Gross Profit
Sales and marketing
General and administrative
Research and development
Impairment expense
Restructuring expense
Supplier settlements
Total other expense, net
Loss before provision for income taxes
 3 Months Ended 6 Months Ended
Dec. 31, 2023 Dec. 31, 2022 Dec. 31, 2023 Dec. 31, 2022

$ 299.4 $ 235 $ 584.8 $ 452.2

(230.3) (217.1) (376.4) (355.8)
(160.8) (192.6) (311.8) (386.1)
(79.9) (80) (158.6) (168.1)
(3.6) (9.7) (27.7) (72.6)
(13.4) (49) (31.2) (155.9)
1.5 (17.9) 1.5 (19.1)
(9.5) (2.2) (35.7) (35.9)
$ (196.6) $ (333.5) $ (355.1) $ (741.2)
 Label
Accounting Standards Update [Extensible Enumeration]
 Element
us-gaap_AccountingStandardsUpdateExtensibleList
 Value
Accounting Standards Update 2020-06 [Member]